CONFERENCE INFORMATION

Home > Conference Information

To read the scientific committee member's biosketch, click on their name.

Brad Gessner
Brad Gessner
Independant Consultant - EpiVac Consulting
Phil Krause
Phil Krause
Independant Consultant
Liz Miller
Liz Miller
London School of Hygiene and Tropical Medicine
Joshua Nealon
Joshua Nealon
Sanofi
Christopher Nelson
Christopher Nelson
Real World Strategy Partners LLC
Dean Smith
Dean Smith
HealthCanada
Evan Anderson
Evan Anderson
Moderna
Tor Biering-Sorensen
Tor Biering-Sorensen
Copenhagen University Hospital
Brad Gessner
Brad Gessner
Independant Consultant - EpiVac Consulting
Brenda Gomes
Brenda Gomes
ANVISA
Nicky Klein
Nicky Klein
Kaiser Permanente
Abstract
Phil Krause
Phil Krause
Independant Consultant
Shabir Madhi
Shabir Madhi
University of Witwatersrand
Stephanie Morain
Stephanie Morain
Johns Hopkins Berman Institute of Bioethics
Abstract

Abstracts are uploaded upon receipt.

DAY 1: November 18, 2026

PHI perspective on value and role of pragmatic RCTs
Nick Andrews, MHRA
Abstract

 

Core design considerations
Arto Palmu, Finnish Vaccine Research
Abstract

 

Safety Monitoring in Pragmatic Trials
Rachael Williams, Medicines and Healthcare products Regulatory Agency
Abstract

 

DAY 2: November 19, 2026

Ethical Considerations for Pragmatic Trials with Vaccines
Stephanie Morain, Johns Hopkins Berman Institute of Bioethics
Abstract

Access to meeting’s slides is given to meeting’s participants for a period of 4 weeks after the meeting.
Login and password are sent by email to participants right after the meeting.
Afterwards the slides are only accessible to IABS members, using their Member Login and Password.

The International Alliance for Biological Standardization (IABS) is an independent, non-profit scientific Alliance, governed by Articles 60-79 of the Swiss Civil code and by its Constitution. Its office is located in Geneva (Switzerland). IABS has members in over 50 countries.

OFFICERS

MISSION

The mission of the Alliance which is related to the scientific and medical advancement of Biologicals, includes :

  • To host conferences and workshops, facilitate communication, and develop consensus on key contemporary issues related to biologicals among those who discover, develop, produce and regulate biological products for human and animal health
  • To foster evidence-based Science as the standard for improving and ensuring the quality and the safety of biological products
  • To share scientific advancements and innovative regulatory solutions through our journal “Biologicals”.

PUBLICATIONS

Reports and proceedings of IABS conferences and workshops appear in its journal Biologicals, published by Elsevier.

MEMBERSHIP BENEFITS

  • Affiliations with a global community of recognized experts
  • Exclusive access to archived information from scientific events (library of speaker presentations, conclusions and recommendations)
  • Reduced fees for a subscription to the journal Biologicals
  • Voting rights for matters discussed during the Biennial IABS General Assembly (Elections, Constitutional changes)

For more information on how to become a member of IABS, please visit: www.iabs.org